{"qas": [{"question": "If a person has TB that's resistant to rifampicin and isoniazid, which type of the disease do they have?", "id": "5727b0c23acd2414000de9db", "answers": [{"text": "MDR-TB", "answer_start": 462}], "is_impossible": false}, {"question": "What's the minimum number of second-line medication classes your TB would have to resist to make it count as \"extensively drug-resistant\"?", "id": "5727b0c23acd2414000de9dc", "answers": [{"text": "three", "answer_start": 618}], "is_impossible": false}, {"question": "In what country was the first case of totally drug-resistant tuberculosis?", "id": "5727b0c23acd2414000de9dd", "answers": [{"text": "Italy", "answer_start": 774}], "is_impossible": false}, {"question": "What's the only antibiotic that might be effective against totally drug-resistant TB?", "id": "5727b0c23acd2414000de9de", "answers": [{"text": "Bedaquiline", "answer_start": 860}], "is_impossible": false}, {"question": "Cases of totally drug-resistant TB have been found in what country in addition to Italy and India?", "id": "5727b0c23acd2414000de9df", "answers": [{"text": "Iran", "answer_start": 844}], "is_impossible": false}, {"plausible_answers": [{"text": "secondary (acquired) resistance", "answer_start": 136}], "question": "Someone who is not susceptible to MTP develops what?", "id": "5a871d531d3cee001a6a10d8", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "compliance", "answer_start": 273}], "question": "What is low-quality medication an example of a lack of?", "id": "5a871d531d3cee001a6a10d9", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "Totally drug-resistant TB", "answer_start": 673}], "question": "What was first reported in Iran?", "id": "5a871d531d3cee001a6a10da", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "2003", "answer_start": 766}], "question": "When was MDR-TB first observed?", "id": "5a871d531d3cee001a6a10db", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "Italy", "answer_start": 774}], "question": "Where was bedaquiline created?", "id": "5a871d531d3cee001a6a10dc", "answers": [], "is_impossible": true}], "context": "Primary resistance occurs when a person becomes infected with a resistant strain of TB. A person with fully susceptible MTB may develop <b5_0>secondary (acquired) resistance<b5_0/> during therapy because of inadequate treatment, not taking the prescribed regimen appropriately (lack of <b6_0>compliance<b6_0/>), or using low-quality medication. Drug-resistant TB is a serious public health issue in many developing countries, as its treatment is longer and requires more expensive drugs. <a0_0>MDR-TB<a0_0/> is defined as resistance to the two most effective first-line TB drugs: rifampicin and isoniazid. Extensively drug-resistant TB is also resistant to <a1_0>three<a1_0/> or more of the six classes of second-line drugs. <b7_0>Totally drug-resistant TB<b7_0/> is resistant to all currently used drugs. It was first observed in <b8_0>2003<b8_0/> in <a2_0><b9_0>Italy<b9_0/><a2_0/>, but not widely reported until 2012, and has also been found in <a4_0>Iran<a4_0/> and India. <a3_0>Bedaquiline<a3_0/> is tentatively supported for use in multiple drug-resistant TB."}